In this review, we will describe how this signaling pathway works in physiological conditions and summarize the most important findings related to the role of NRF2/KEAP1 in LUAD and LUSC, focusing on their activation mechanisms and their implications in the progression of cancer. The gene discussed is NFE2L2; the disease is cancer.